← Browse by Condition
Medical Condition
pancreatic ductal adenocarcinoma pdac
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for pancreatic ductal adenocarcinoma pdac sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — pancreatic ductal adenocarcinoma pdac Clinical Trials
How many clinical trials are currently recruiting for pancreatic ductal adenocarcinoma pdac?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for pancreatic ductal adenocarcinoma pdac, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pancreatic ductal adenocarcinoma pdac?
pancreatic ductal adenocarcinoma pdac research spans Phase 1 (5 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pancreatic ductal adenocarcinoma pdac clinical trial?
Eligibility criteria for pancreatic ductal adenocarcinoma pdac trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 5
Phase 2 4
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07480928 Phase 1, Phase 2
Recruiting
Enrollment
42 pts
Location
China
Sponsor
Beijing Biotech
NCT07224750
Recruiting
Enrollment
1,000 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT07227168 Phase 1
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
Sutro Biopharma, Inc.
NCT07912593 Phase 1, Phase 2
Recruiting
Enrollment
320 pts
Location
United States
Sponsor
Ensem Therapeutics
NCT07255404 Phase 2
Recruiting
Enrollment
105 pts
Location
Australia, China
Sponsor
BioNTech SE
NCT07787156
Recruiting
Enrollment
80 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT06040541 Phase 1
Recruiting
Enrollment
604 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT07683845
Recruiting
Enrollment
164 pts
Location
China
Sponsor
Beijing Daxiang Biotech Co., L...
NCT07235202 Phase 1, Phase 2
Recruiting
Enrollment
45 pts
Location
China
Sponsor
Shenzhen Majory Biotechnology ...
Related Conditions
non small cell lung cancer nsclc (2) unresectable locally advanced or metastatic disease (1) hepatocellular carcinoma hcc (1) cholangiocarcinoma (1) esophageal squamous cell carcinoma escc (1) gastric cancer gc (1) colorectal cancer screening (1) head and neck squamous cell carcinoma hnscc (1) esophageal cancer (1) gastric cancer (1) colorectal cancer (1) cervical cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology